50
Participants
Start Date
June 20, 2022
Primary Completion Date
January 17, 2025
Study Completion Date
December 31, 2025
Dexmedetomidine Hydrochloride
Potent α2-adrenergic receptor agonist that provides sedation, analgesia, and prevents shivering but does not suppress ventilation.
Morphine Sulfate
Opioid agonist that provides analgesia, pain management and sedation and may suppress ventilation.
Intermountain Medical Center, Murray
Primary Children's Hospital, Salt Lake City
University of Utah Health, Salt Lake City
McKay-Dee Hospital, Ogden
Utah Valley Hospital, Provo
University of Utah
OTHER